We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Angioplasty Offers Symptom Relief for MS Patients

By HospiMedica International staff writers
Posted on 11 Jun 2012
Angioplasty of the azygos and jugular veins is safe and improves the quality of life (QOL) for those with multiple sclerosis (MS), according to a new study.

Researchers at Albany Medical Center (NY, USA) treated 192 patients (72 men, 141 women; average age 49 years) that included 96 individuals with relapsing remitting MS, 66 with secondary progressive MS, and 30 with primary progressive MS. More...
The study population included those who underwent angioplasty alone, and three who underwent angioplasty with a stent. All patients filled in a standard questionnaire that evaluated key QOL components, including changes in physical abilities, health perception, energy/fatigue, sexual function, emotional well-being, cognition, and pain.

The results showed significant physical improvements in 75% of those with relapsing remitting and primary progressive forms of MS. Additionally, mental health scores improved in more than 70% of the individuals studied. People with secondary progressive MS also showed statistically significant improvements in both physical and mental health scores at a rate of 59% and 50%, respectively. In addition, the researchers found a trend that patients undergoing angioplasty more than 10 years after diagnosis did not respond as well as those with a more recent diagnosis. The study was presented at the Society of Interventional Radiology's 37th annual scientific meeting, held during March 2012 in San Francisco (CA, USA).

“Traditional theories surrounding treatment for multiple sclerosis in large part focus on autoimmune causes for brain pathology and neurologic symptoms. Based on this, treatment has been predominantly medications by mouth or injection,” said lead author and study presenter interventional radiologist Kenneth Mandato, MD. “We have been using angioplasty to open jugular and azygos veins in the neck and chest respectively to improve blood flow in people with MS. On follow-up, we have seen many of these individuals report significant symptom relief.”

MS is an inflammatory disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs and symptoms resulting from the inability of nerve cells in the brain and spinal cord to communicate with each other effectively. Disease onset usually occurs in young adults, and it is more common in women. The name multiple sclerosis refers to scleroses (scars), particularly in the white matter of the brain and spinal cord, which is mainly composed of myelin.

Related Links:
Albany Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.